RxDoctor Payments DataLook up a doctor →

Kamran Siddiqui, MD

Internal Medicine · Elkhart, INNPI 1871596700

Payments from drug & device makers

$17,661in general payments, 2019–2025

Across 1,175 payments — averaging $15.03 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AstraZeneca$3K
  • Lilly USA, LLC$2K
  • Novo Nordisk$1K
  • Merck$1K
  • AbbVie$977
  • Abbott$825
  • plus $9K from 51 others

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
AstraZeneca(2 entities)110$2,617
Lilly USA, LLC110$1,602
Novo Nordisk109$1,220
Merck97$1,157
AbbVie(2 entities)58$977
Abbott52$825
Boehringer Ingelheim59$763
GSK61$736
Bayer46$696
Pfizer52$622
Mylan Specialty L.p.31$582
Xeris Pharmaceuticals, Inc.32$485
Esperion Therapeutics, Inc.37$482
Amgen34$466
Johnson & Johnson36$429
Inspire Medical Systems, Inc.26$402
Novartis30$381
Sumitomo Pharma America, Inc.16$274
Sunovion Pharmaceuticals Inc.22$259
Astellas Pharma US Inc11$229
Amneal Pharmaceuticals LLC14$203
Sanofi-aventis U.S. LLC10$175
IBSA Pharma Inc.12$169
Insulet Corporation7$159
Viatris Specialty LLC9$148
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC10$140
Dexcom, Inc.9$132
Amarin Pharma, Inc.9$127
Radius Health, Inc.7$125
Recordati_rare_diseases_inc.5$104
Neurocrine Biosciences, Inc.4$96
Lundbeck LLC5$92
Otsuka America Pharmaceutical, Inc.5$90
Exact Sciences5$74
Eisai Inc.3$51
BETA Bionics, Inc.2$46
Biohaven Pharmaceuticals, Inc.3$39
Vanda Pharmaceuticals Inc.1$37
Kowa Pharmaceuticals America, Inc.3$35
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)2$33
Antares Pharma, Inc.2$32
Shire North American Group Inc2$30
Arbor Pharmaceuticals, Inc.1$29
Amryt Pharma Holdings Ltd2$29
Medtronic(2 entities)2$29
Cequr Corporation1$28
OPKO Pharmaceuticals, LLC1$25
Biocryst US Sales Co., LLC1$24
Ardelyx, Inc.1$22
Kyowa Kirin, Inc.1$22
Ultragenyx Pharmaceutical Inc.1$20
Phathom Pharmaceuticals, Inc.1$20
Lifescan, Inc.1$17
Teva Pharmaceuticals USA, Inc.1$14
Idorsia Pharmaceuticals US Inc1$13
Takeda Pharmaceuticals U.S.A., Inc.1$13
Nevro Corp.1$13

How this compares

$17,661 in reported general payments places this provider in the 95th percentile of 1,747 internal medicine providers in Indiana.

See all internal medicine providers in Indiana →

Medicare billing

Part B allowed, 2024
$494,863
Medicare patients
396
Services billed
22,811

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other internal medicine in Elkhart

See the full list for Indiana →

Where these figures come from

Is this you, or does something look wrong? →